CRISPR-based Biosensor Platform for Rapid Pathogen Detection in Food

Chapter ONE

INTRODUCTION

• 1.1Introduction CRISPR-based Biosensor Platform for Rapid Pathogen Detection in Food: An ICT-driven approach to real-time, point-of-care pathogen surveillance in the food supply chain.
• 1.2Background of the Study Overview of foodborne pathogens, current detection bottlenecks, and the emergence of CRISPR-Cas systems integrated with microfluidics, smartphones, and edge computing for rapid, on-site sensing.
• 1.3Statement of the Problem Limitations of conventional culture-based and immunoassay methods in speed, sensitivity, and field deployability; the need for scalable, low-cost, user-friendly CRISPR-based detection in food matrices.
• 1.4Aim and Objectives of the Study Aim: Develop and validate a CRISPR-based biosensor platform for rapid, accurate pathogen detection in diverse food matrices using ICT-enabled readouts. Objectives: (1) design CRISPR-Cas sensors targeting major foodborne pathogens; (2) integrate microfluidics with portable electronics; (3) develop smartphone-based data capture and cloud analytics; (4) evaluate sensitivity, specificity, and robustness in real foods; (5) assess user usability and field deployment feasibility.
• 1.5Research Questions How can CRISPR-Cas detection be optimized for speed and sensitivity in complex food matrices? What ICT components (microfluidics, mobile app, cloud analytics) best enable real-time reporting and traceability? How does the platform perform across pathogens and food types? What are the hurdles for field deployment and regulatory acceptance?
• 1.6Research Hypotheses H1: The CRISPR-based biosensor achieves lower detection limits and faster turnaround than standard rapid tests in multiple food matrices. H2: ICT integration (mobile app and cloud analytics) enhances data accuracy, traceability, and decision-making for food safety management. H3: The platform maintains performance across diverse pathogens with minimal matrix interference due to optimized sample preparation.
• 1.7Significance of the Study Advances rapid, accurate, field-ready pathogen detection; enables proactive food safety management; supports regulatory compliance and reduces outbreak risk; contributes to the smart food supply chain with real-time data ecosystems.
• 1.8Scope and Delimitation of the Study Focus on selected priority pathogens (e.g., Listeria monocytogenes, Salmonella enterica, Escherichia coli O157:H7) in dairy, meat, and ready-to-eat foods; excludes non-food environmental samples and clinical settings; lab-to-field transition with prototype validation only.
• 1.9Limitations of the Study Potential matrix effects, device calibration challenges across food types, regulatory approval timelines, and generalizability beyond tested matrices.
• 1.10Organisation of the Study Outline of chapters and progression from design to validation and implications for policy and practice.
• 1.11Operational Definition of Terms Definitions of CRISPR-Cas, biosensor, limit of detection, ICT, microfluidics, edge computing, smartphone-based readout, and food matrix interference.

Chapter TWO

LITERATURE REVIEW

• 2.1Conceptual Review: CRISPR-based Detection in Food Safety Foundations of CRISPR-Cas systems for nucleic acid detection and adaptation to food matrices.
• 2.2Conceptual Review: Biosensor Technologies for Food Pathogen Detection Electrochemical, optical, and colorimetric CRISPR-integrated sensors in food contexts.
• 2.3Conceptual Review: ICT-Enabled Food Safety Monitoring Role of mobile devices, cloud platforms, IoT, and data analytics in real-time surveillance.
• 2.4Theoretical Framework: Diffusion of Innovations in Food Safety Tech Adoption How new biosensor ICT solutions spread among stakeholders.
• 2.5Theoretical Framework: Technology Acceptance Model (TAM) for Field Diagnostics Perceived usefulness and ease of use influencing adoption by users in the food chain.
• 2.6Theoretical Framework: Systems Engineering Approach to Integrated Sensing Interoperability, modularity, and scalability considerations for end-to-end platforms.
• 2.7Empirical Review: CRISPR-Based Diagnostics in Food Contexts Summary of existing CRISPR assays, performance metrics, and deployment challenges.
• 2.8Empirical Review: Microfluidic Integration with CRISPR Systems Microfluidic formats, sample prep, and reaction optimization in compact devices.
• 2.9Empirical Review: ICT Components in Biosensing: Mobile Apps, Edge to Cloud Data acquisition, transfer, processing, and visualization in food safety.
• 2.10Empirical Review: Readout Modalities and User Interfaces Optical vs electrochemical readouts, signal robustness, and user ergonomics.
• 2.11Identified Gaps in the Literature Lack of integrated end-to-end platforms validated across real foods with user-centered design and field testing.
• 2.12Conceptual Model/Review Summary Proposed integrative model linking CRISPR sensing, microfluidics, ICT readouts, and data-driven decision support.

Chapter THREE

RESEARCH METHODOLOGY

• 3.1Research Design Applied experimental-developmental study with iterative cycles of design-build-test.
• 3.2Philosophical Paradigm Postpositivist with pragmatist emphasis on practical utility and measurable outcomes.
• 3.3Population of the Study DNA/RNA targets of selected pathogens; representative food matrices and pilot users.
• 3.4Sample Size and Sampling Technique Power-based sample sizing for analytical experiments; purposive sampling of food matrices and user testers.
• 3.5Sources and Instruments of Data Collection CRISPR-detection device, microfluidic chips, smartphone app, cloud dashboard, and standard reference methods.
• 3.6Validity and Reliability of Instruments Analytical validation, calibration curves, inter-device reproducibility, and blinded reference testing.
• 3.7Data Collection Procedures Step-by-step protocol for sample preparation, reaction setup, readout capture, and data transmission.
• 3.8Data Analysis Methods Quantitative analysis of sensitivity, specificity, LOD; ROC analysis; concordance with reference methods; ICT data analytics.
• 3.9Model Specification / Analytical Framework Statistical models for diagnostic performance; data fusion framework for sensor and ICT signals.
• 3.10Ethical Considerations Research ethics, biosafety, data privacy, informed consent for field testers, and environmental impact.
• 3.11Reliability Testing and Quality Assurance Protocol for QA/QC across batches and devices; traceability and version control.
• 3.12Risk Assessment and Mitigation Potential biosafety, data security, and field deployment risks with mitigation plans.

Chapter FOUR

DATA PRESENTATION AND ANALYSIS

• ANALYSIS AND DISCUSSION OF FINDINGS
• 4.1Data Presentation Strategy Structured display of analytical performance and ICT metrics with cross-tabulations.
• 4.2Descriptive Analysis Characterization of device performance across matrices and pathogens; user interaction metrics.
• 4.3Hypotheses Testing Statistical tests for H1–H3; comparison with reference methods; ROC and AUC values.
• 4.4Interpretation of Results Contextualization of sensitivity, specificity, speed, and robustness in real-food scenarios.
• 4.5ICT Readout Performance and Usability Findings Evaluation of smartphone app usability, data latency, and cloud analytics efficacy.
• 4.6Matrix Interference and Pre-Analytical Variability Assessment of food composition impacts on assay performance.
• 4.7Cross-Pathogen and Cross-Matrix Generalizability Assessment of platform versatility and limits of detection by matrix/pathogen.
• 4.8Discussion in Relation to Reviewed Literature How findings align or diverge from prior studies and theoretical models.

Chapter FIVE

SUMMARY, CONCLUSION AND RECOMMENDATIONS

• CONCLUSION AND RECOMMENDATIONS
• 5.1Summary of Findings Concise synthesis of analytical and ICT performance outcomes.
• 5.2Conclusion Overall assessment of platform viability for rapid pathogen detection in foods.
• 5.3Contribution to Knowledge Advancement in integrated CRISPR-ICT biosensing for food safety.
• 5.4Recommendations Technical refinements, field deployment strategies, regulatory considerations, and scalability.
• 5.5Suggestions for Further Studies Future work on broader pathogen panels, diverse foods, and advanced analytics.